MedImmune Inc., a biotechnology company based in Gaithersburg, has appointed Peter S. Greenleaf as its new senior vice president of sales and marketing.

Greenleaf will be responsible for leading the company’s global commercial organization and developing strategies to ensure the success of MedImmune’s current and future portfolio commercialization.

“The addition of Peter to our team is the capstone of a series of steps to strengthen our commercial organization and to prepare for the opportunities that lie ahead,” David M. Mott, the company’s president and chief executive officer, said in a statement.

“Peter is a high-energy professional who brings both marketing and sales management experience as well as entrepreneurial biotechnology background, which he will apply to leading our more than 550 professional in the marketing and sales organization.”

This story continues below
Advertisement

Prior to his position with MedImmune, Greenleaf was a vice president at Centocor Inc.

bmiller@baltimoreexaminer.com